Share

    


Home / Search Results

Search Results

You searched for:

    Displaying results 21 - 40 of 54
  • «
  • 1
  • 2
  • 3
  • »
COVID-19 has brought an unexpected, unwelcome, and unwanted disruption to oncology care, as it has to every other facet of life. ACCC has met this unprecedented pandemic, however, with its characteristic “how to” approach.
What Can Be Done? BY CHRISTIAN G. DOWNS, JD, MHA Over the last several months one healthcare issue has been the focus of attention, globally, nationally, locally, and personally: COVID-19. Though it is too soon to comprehend all of the lessons learned from the pain, suffering, deaths, and devastation the novel coronavirus 2019 has brought, we are reminded that diseases do not …
Policy Round Up BY CHRISTIAN G. DOWNS, JD, MHA In this election year, U.S. healthcare policy is center stage. To help its members keep current on recent policy issues that may affect their programs and patients, ACCC provides a brief update. CY 2021/2022 Medicare Advantage and Part D Proposed Rule On Feb. 5, the Centers for Medicare & Medicaid Services (CMS) released CMS- 4190-P, which …
May 30, 2020, marks the two-year anniversa- ry of the passage of the federal Right to Try law. Like the ex- periences in states that have passed similar legislation, there was consider- able debate over the benefits versus harms that a national Right to Try law would usher in. Proponents argued that existing process- es for patients seeking non-U.S. Food and Drug Administration …
Eyes on Cancer provides a 20-minute online educational video about the different types of skin cancer with photos of each kind, a melanoma lesion photo reference card within the video, and an online 35-question post-test. When finished, hairdressers can print and display a certificate of completion in their salon.
As we begin 2020 and an election year, drug pricing is center stage in healthcare politics.
The Centers for Medicare and Medicaid Services (CMS) released the final Medicare payment rules for calendar year (CY) 2020 in tandem this year on Nov. 1, 2019.
On Sept. 27, ACCC provided comments to the Centers for Medicare & Medicaid Services (CMS) on the agency’s proposed CY 2020 Outpatient Prospective Payment System (OPPS) and Physician Fee Schedule (PFS) rules.
For nearly 30 years, TOPS has served oncologists and patients in Tennessee. The organization has focused primarily on issues related to the delivery of the highest quality cancer care, while also working to deter threats to the viability of the community practice model.
On July 10, 2019, the Centers for Medicare & Medicaid Services (CMS) revealed new details of a proposed bundled payment model for radiation oncology services (“RO Model”).
Entering the second quarter of 2019—with a dramatically different Congress—here’s a quick peek at what to expect for your program, your patients, and oncology delivery overall in the coming months.
CRISPR, a gene editing tool, has entered the scientific arena and public discourse at an astounding speed. Eric B. Kmiec, PhD, director of the Gene Editing Institute at the Helen F. Graham Cancer Center & Research Institute, discusses the emergence of gene editing, how it can be utilized as a tool in the battle against cancer, and the challenges facing its transition from bench to bedside.
Make Your Voice Heard at ACCC Capitol Hill Day BY BLAIR BURNETT Every two years American voters go to the polls to participate in national elections. This fall’s mid-term elections resulted in a major paradigm shift and an entirely different congressional class. With this shake-up in Washington, D.C., new voices are demanding to be heard. Make yours one of them. Each year, in conjunction …
On Sept. 21, the Biden Cancer Initiative Summit convened in Washington, D.C., and was joined by 450 community summits across the country to bring together those who work to improve the cancer experience for patients and caregivers.
QA 2019 MEDICARE PRESCRIPTION DRUG ANNUAL OPEN ENROLLMENTThe Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2018 – December 7, 2018 for coverage beginning January 1, 2019. Certain people with Medicare can also change plans at other times (see question #10). Plans make changes to benefits and costs, and there are also new plans in many areas …
Although the Trump administration has maintained a steady drumbeat on pharmaceutical pricing in recent months, promising lower costs for patients and less spending for the government, it wasn’t until late summer that we started to see what this White House had in mind.
Microsoft Word - ACCC Comments re HHS Blueprint RFI Final OFFICER President Thomas A. Virginia Ca Richmond, President- Ali McBrid The Univer Tucson, Ar Treasurer Randall A. Lancaster G Lancaster, Secretary Krista Nels Providence Portland, O Immediate Mark S. So James M. S Frederick, TRUSTEE Olalekan A Welch Can Sheridan, W Nadine J. B Office of H Duke Canc Durham, N Catherine …
Secretary Alex Azar has expressed strong interest in revitalizing Medicare’s Competitive Acquisition Program (CAP) and introducing negotiation into Part B drug pricing.
As policymakers seek legislative solutions to the opioid crisis, it is imperative to recognize that broad opioid bills that do not specifically address the issue of different types of pain run the risk of harming our vulnerable cancer patient population in terms of adequately treating cancer-related pain.
issues Advocacy 365 BY LEAH RALPH On the Association of Community Cancer Centers’ (ACCC) Capitol Hill Day, March 14, an energetic contingent of ACCC members walked the halls of Congress speaking up on behalf of access to quality cancer care in nearly 100 congressional meetings with legislators. Thanks to our dedicated group of advocates, ACCC reached 44 unique house districts and 52 unique …
    Displaying results 21 - 40 of 54
  • «
  • 1
  • 2
  • 3
  • »